Evgen Pharma (EVG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 18.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 25.30
  • 52 Week Low: 12.75
  • Currency: UK Pounds
  • Shares Issued: 93.36m
  • Volume: 35,403
  • Market Cap: 16.80m
  • RiskGrade: 319
  • Beta: 0.01

Evgen Pharma Overview

Evgen Pharma is in the pharma and biotech sector and is currently trading at 18.00p per share. In the last year Evgen Pharma's share price has ranged from 12.75p to 25.30p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (16-08-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 4.3  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Evgen Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-15 n/a (2.30) (7.79)p n/a n/a n/a n/a 0.0%
31-Mar-16 n/a (3.22) (6.29)p n/a n/a n/a n/a 0.0%
31-Mar-17 n/a (3.64) (4.19)p n/a n/a n/a n/a 0.0%
31-Mar-18 n/a (3.03) (3.28)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Evgen Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-19 n/a (4.07) (3.32)p n/a n/a n/a n/a 0.0%
31-Mar-20 3.75 (0.13) 0.29p 63.2 n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Evgen Pharma Company Announcements

Result of AGM 26-Jul-2018 15:22 RNS
AGM Statement 26-Jul-2018 07:00 RNS
Final Patient Recruited in STEM Phase IIa Trial 25-Jul-2018 07:00 RNS

Latest Evgen Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Evgen Pharma Market Data

Currency UK Pounds
Share Price 18.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 25.30
52 Week Low 12.75
Volume 35,403
Shares Issued 93.36m
Market Cap 16.80m
Beta 0.01
RiskGrade 319

Evgen Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.02% below the market average40.02% below the market average40.02% below the market average40.02% below the market average40.02% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average
Price Trend
7.43% above the market average7.43% above the market average7.43% above the market average7.43% above the market average7.43% above the market average
35.38% above the sector average35.38% above the sector average35.38% above the sector average35.38% above the sector average35.38% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Evgen Pharma Dividends

No dividends found

Trades for 16-Aug-2018

Time Volume / Share Price
16:22 2,770 @ 18.05p
14:40 30,000 @ 18.08p
14:36 2,500 @ 17.69p
09:04 133 @ 18.08p

Evgen Pharma Key Personnel

CEO Stephen Franklin
CFO Richard Moulson

Top of Page